Press release
Generalized Pustular Psoriasis Market Trends Shaped by Biologics Demand and Personalized Dermatology 2025-2033 | Bristol Myers Squibb, UCB, Inc, Pfizer Inc., AbbVie Inc., Novartis AG
Generalized Pustular Psoriasis Market
Generalized Pustular Psoriasis Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/generalized-pustular-psoriasis-market?ophp
Generalized pustular psoriasis (GPP) is a rare, severe form of psoriasis marked by widespread pustules and systemic symptoms. The treatment market is evolving with approvals of targeted biologics such as IL-36 inhibitors and ongoing trials addressing the need for rapid, effective, and safe therapies in acute flares.
Generalized Pustular Psoriasis Market Competitors Overview:
Bristol Myers Squibb, UCB, Inc, Pfizer Inc., AbbVie Inc., Novartis AG, Astellas Pharma Inc., Eli Lilly and Company, Amgen Inc., Johnson & Johnson, AstraZeneca among others.
Important Industry Updates of 2023, 2024 and 2025:
✅ Vanda Pharmaceuticals secured exclusive global rights to develop and commercialize imsidolimab, an IL‐36 receptor antagonist antibody, from AnaptysBio. The asset has completed successful Phase 3 trials (GEMINI‐1 and GEMINI‐2), showing rapid clearance of pustular lesions and strong safety in GPP patients
Methodology and Scope
The Generalized Pustular Psoriasis Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/generalized-pustular-psoriasis-market?ophp
Generalized Pustular Psoriasis Market Segments Overview:
∎ By Treatment (Topical Agents (Calcipotriol, TacrolimusNon-biologic agents (Cyclosporin, Methotrexate, Oral Retinoids, Others), Biologic agents (Interleukin antagonists, Guselkumab, Brodalumab, Others, TNFα antagonists (Adalimumab, Certolizumab), Antibiotics, Others))
∎ By Route of Administration (Oral, Topical, Subcutaneous, Other)
∎ By End User (Hospitals, Dermatology Clinics, Specialty Centers, Others)
Regional Overview for Generalized Pustular Psoriasis Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=generalized-pustular-psoriasis-market?ophp
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generalized Pustular Psoriasis Market Trends Shaped by Biologics Demand and Personalized Dermatology 2025-2033 | Bristol Myers Squibb, UCB, Inc, Pfizer Inc., AbbVie Inc., Novartis AG here
News-ID: 4114238 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Population Health Management Market 2025 | Growth Drivers, Key Pla …
Market Size and Growth
The Global Population Health Management Market reached USD 21.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 54.3 billion by 2031. The global population health management market is expected to exhibit a CAGR of 12.8% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In August 2025, the U.S. digital health sector attracted $7.5 billion in funding during H1…
United States Autonomous Vehicle Market 2025 | Growth Drivers, Market Forecast, …
Market Size and Growth
The Global Autonomous Vehicle Market growing at a CAGR of 35.7% during the forecast period (2023-2030).
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Lucid Motors began its collaboration with Uber and Nuro by delivering the first Lucid Gravity SUV for retrofitting into an autonomous robotaxi. This marks the commencement of a plan to deploy 20,000 such vehicles across the U.S. over the next six years.
✅…
United States Indoor Farming Market 2025 | Growth Drivers, Key Players & Investm …
Market Size and Growth
The Global Indoor Farming Market reached USD 34.2 billion in 2022 and is expected to reach USD 56.1 billion by 2031 and is expected to grow with a CAGR of 6.4% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Gotham Greens announced the successful scaling of urban agriculture by combining vertical and horizontal growing methods in greenhouse-style facilities across multiple U.S.…
United States Cosmetic Antioxidants Market 2025 | Growth Drivers, Key Players & …
Market Size and Growth
Global Cosmetic Antioxidants market is estimated to grow at a CAGR of 6.1% during the forecast period 2024-2031
Recent Mergers and Acquisitions:
United States: Recent M&A Activity
✅ In May 2025, e.l.f. Beauty acquired Rhode, the skincare brand founded by Hailey Bieber, for approximately $1 billion. This strategic move aims to strengthen e.l.f.'s position in the premium beauty segment and expand its Gen Z consumer base.
✅ In September 2025,…
More Releases for Generalized
Key Trends Influencing the Growth of the Generalized Anxiety Disorder Market in …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Generalized Anxiety Disorder Market Through 2025?
In recent years, there has been a consistent expansion in the market size for generalized anxiety disorder. The market, which is predicted to grow from $7.76 billion in 2024 to $8.01 billion in 2025, will experience…
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Key Generalized Anxiety Disorder Market Trend for 2025-2034: Innovative Drug Dev …
"What Is the Future Outlook for the Generalized Anxiety Disorder Market's Size and Growth Rate?
The generalized anxiety disorder market will grow from $7.76 billion in 2024 to $8.01 billion in 2025, at a CAGR of 3.2%. Growth is driven by increased mental health awareness, pharmaceutical advances, the popularity of cognitive-behavioral therapy (CBT), and the stressful lifestyle changes of modern society.
The generalized anxiety disorder market is expected to reach $9.32 billion…
Global Generalized Anxiety Disorder Treatment Market Imapct of AI and Automation
Generalized Anxiety Disorder Treatment Market Impact of AI and Automation
The Generalized Anxiety Disorder (GAD) treatment market has been experiencing significant growth due to the increasing prevalence of anxiety disorders globally, rising awareness about mental health, and the development of advanced therapeutic options. In 2022, the market size was valued at approximately USD 7.5 billion and is expected to grow at a compound annual growth rate (CAGR) of around 6.5% from…
Generalized Anxiety Disorder Market Report and Forecast 2024-2032
Generalized Anxiety Disorder Market Outlook
The generalized anxiety disorder market size in the 7 major markets was valued at USD 1717.5 million in 2023, driven by the increasing advancements in psychotherapeutic as well as pharmacological treatment options for patients. The market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1809.8 million in 2024 to USD 2751.1…
Generalized Anxiety Disorder Pipeline Insight Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Generalized Anxiety Disorder Pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized Anxiety Disorder Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Generalized Anxiety Disorder Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Generalized…
